Abstract No. 526 CheckMate-9DX: Phase 3, Randomized, Double-Blind Study of Adjuvant Nivolumab Vs Placebo for Patients with Hepatocellular Carcinoma (HCC) at High Risk of Recurrence after Curative Resection or Ablation
Journal of Vascular and Interventional Radiology（2019）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined